April 09, 2019
Cergentis releases two new application notes: improving QC in cell & gene therapy manufacturing with TLA
March 05, 2019
Cergentis’ TLA technology and Genedata software: efficient in-house data analysis for CHO cell line development
October 02, 2018
New Glenmark paper: TLA and clonal derivation assessment of (CHO) cell lines
September 13, 2018
Cergentis & Princess Máxima Center collaborate on MRD test development for leukemia and solid tumours
June 13, 2018
Cergentis’ CEO invited to present TLA technology at ACTIP meeting in Dusseldorf
See how our proprietary genomic analysis platform compares to conventional approaches such as WGS and FISH
Read application notes published by Cergentis and its partners.
Our TLA-based genetic QC solutions have been widely published and recognized. View more than 50 peer-reviewed papers, published by our customers and partners.
Watch our webinar recordings to find out more information about our genetic QC solutions in various applications.